Cadila Healthcare is currently trading at Rs. 426.85, up by 14.00 points or 3.39% from its previous closing of Rs. 412.85 on the BSE.

The scrip opened at Rs. 412.00 and has touched a high and low of Rs. 427.15 and Rs. 412.00 respectively. So far 98851 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 428.50 on 08-Oct-2020 and a 52 week low of Rs. 212.70 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 428.50 and Rs. 396.10 respectively. The current market cap of the company is Rs. 42971.60 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 17.15% and 7.78% respectively.

Zydus Cadila has launched Forglyn pMDI, India’s first pressurized Metered Dose Inhaler (pMDI) with a combination of Long Acting Muscarinic Antagonist (LAMA) and Long Acting Beta Agonist (LABA) for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) in India. Forglyn pMDI is priced at Rs 495 per pack and has been developed in-house using Zydus’ innovations in formulation technology.

The administration of the two drugs Formoterol fumarate (LABA) plus Glycopyrrolate (LAMA) in a single inhalation will improve outcomes due to the desired synergistic effect of the two drugs and a better adherence to the treatment.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

1037.80 -12.55 (-1.19%)
29-May-2024 10:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1473.00
Dr. Reddys Lab 5928.40
Cipla 1483.00
Zydus Lifesciences 1037.80
Lupin 1595.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.